Sept 5-6
Sept 5-6
Sept 5-6
DAILY CENSUS
SEPTEMBER 5-6, 2023
COC DR. ALEJANDRO
PGI SARAYAN/IRENEA/ARARAL/INSULAR/PIQUIT/FABIAÑA
CLERKS INAMARGA/HUSAIN/GIO/LINOGAO/YU/LANCARA
DISPOSITION
NUMBER OF VACANCIES PER AREA
ADMISSIONS 9
UNIT VACANT RIGHT LEFT
ER REFERRALS 1
GEN MED 1 P: 1 1-7 48-52
NEW WARD REFERRALS 2 MW (50): 1 1`
CW (51): 2
HOLDING AREA/ ER ISOLATION 0
FW (52): 0
TRANSFERRED TO ICU 0 GEN MED 2 3 8-15 38– 47
SURGERY WING 12
EXECUTIVE WING 7
FAMMED WING 7
PICU 0
OB WING 0
DR/LR 0
ICU 2
ICU EXTENSION 0
PEDIA WING 0
TOTAL IM IN-PATIENTS
ADMISSIONS: 9
09/05/23 22 DIONGSON, 86/M DECREASED Acute CVA Infarct prob posterior Cerebral artery Dr. Licayan (PC) Dr. A PNSS 1L @ 100 cc/hr
AMIE SENSORIUM NIHSS - 8 HCVD Abou zaki (CM) D Soft diet with strict aspiration precaution
M VS q4, NVS 4, I and O q shift
I
U (70
M
1. Atorvastatin 80 mg 1 tab OD HS
2. Citicoline 1 gm IV q 12
3.CARVEDILOL 6.25MG TAB BID
4.OMEPRAZOLE 40MG TAB 1 TAB OD
SENOKOT FORTE 1 TAB OD HS
L
09/05
CRANIAL CT SCAN PLAIN
IMPRESSION:
ACUTE NON-HEMORRHAGIC INFARCT, RIGHT OCCIPITAL LOBE
CHRONICE INFARCT, LEFT PARIETAL LOBE
CEREBRAL AND CEREBELLAR ATROPHY
BILATERAL INTERNAL CAROTID AND VERTEBRAL
ATHEROSCLEROSIS
CHRONIC MAXILLARY SINUSITIS,LEFT
CXR
IMPRESSION:
PULMONARY CONGESTION
LEFT VENTRICULAR CARDIOMEGALY
ATHEROSCLEROTIC AORTA
THORACIC SPONDYLOSIS
CBC
WBC 12.0
RBC 5.5
HGB 16.5
HCT0.49
PLT 230
N 0.84
L 0.09
M 0.04
E 0.02
B 0.01
MG 0.65
CA 1.12
CREA 101
K 3.08
NA 142.7
FT4 0.98
TSH
SUA 535
HBA1C 5.5
U
09/05
Conferred with Dr. Licayan
Start Amiodarone 200 mg 1 tab TID
Refer to Dr. Abuo zakit for co-mgt
09/05/23 RM19 LLOREN, JOEL 54/M RUQ PAIN CHOLEDOCHOLITHIASIS DR. VELASCO (PC) A D5NSS 1L AT 100CC/HR
GM3 D LOW FAT DIET
M VS Q4HRS; I/O QSHIFT
I
U CPK
M
1. VITAMIN K 10MG IN 50ML NSS IN SOLUSET TO RUN IN 30 MINS
Q8HRS
2. AMPICILLIN + SULBACTAM (AMSULVEX 1.5MG IVTT Q8HRS (TO
START AT ER)
3. DOLCET TABLET, 1 TABLET EVERY 8HRS AS NEEDED FOR PAIN
4. PANTOVEX 40MG IVTT AT 6AM ON THE DAY PRIOR TO ERCP
L
09/05
WBC 6.9
RBC 4.0
HGB 12.4
HCT 0.38
PLT CT 257
N 0.79
L 0.15
M 0.04
CXRAY
NEGATIVE CHEST XRAY
PROTIME
U
09/05
09/05/23 30 Revilla, 74/M Edema Pulmonary congestion prob secondary to Heart DR. OMBAO (HC) A PNSS @ KVO
Narciso failure D low salt Low fat, DM
Chronic Venous Insufficiency MVS q4, I/O q shift
Hypertensive Cardiovascular Disease, Heart Failure I
FC III U
Anemias prob sec to CKD sec to DKD/ HKD M
T2 DM 1. Albumin 20% + 40 mg Furosemide x 4 hours q 12 hours
S/P CVA with left sided residual weakness (congestion precaution)
2. Mg so4 2 gm + 20 cc NSS slow iv q8 x 2 doses
3. Trimag 1 tab TID
4. RI Sliding scale
CBG RI SQ
180-220 4 units
221-260 6 units
261-300 8 units
>300 10 units
L
09/05
CBG 130 mg/dl
ECG Sinus tachycardia, RBBB incomplete
WBC 9.7
Hgb 8.8
Hct 0.26
Plt 244
N 0.71
L 0.20
M 0.08
Albumin 18
Na+ 137.0
K+ 3.92
Ca++ 1.17
Mg+ 0.57
U
09/05
09/05/23 3 CARTAJENA, 74/M DYSPNEA Pleural Effusion Left prob parapneumonic DR. B. RAMOS (PC) A PNSS @ KVO
SEGUNDINO CAP - MR
End Stage Renal Disease Secondary to HKD D low salt Low fat renal
HCVD, CAD, LVH
M VS q4, I/O q shift
2. Amlodipine 10 mg 1 tab OD
3. Losartan 50 mg 1 tan OD
5. Aspirin 80 mg 1 tab OD
6. Clopidogrel 75 mg 1 tab OD
7. Atorvastatin 40 mg 1 tab OD
8. Ferrous Sulfate + Folic Acid 1 tab BID
09/05
CBC
Wbc 9.8
Plt 280
N 0.74 (H)
M 0.07
L 0.17 (L)
E 0.01
CXRAY
ECG
Creatinine BUN
SGPT, Phosphorous
Pro BNP
UTZ of Chest
Blood cs x 2 sites
Sputum GSCS
09/05
09/05/23 219-C HINGGOS, 64/M NON HEALING Non healing wound, left anterior shin DR. R. TAN (PC) A PNSS 1L@ 100 CC/HR
ANECITA WOUND, LEFT Type II diabetes mellitus
ANTER D diabetic diet; allergic to chicken and seafood
I Piptaz D0
U cpk
09/05
WBC
RBC
HGB
HCT
PLT CT
M
Blood culture 2 sites
Wound gscs
Na
CBG
UA
AV duplex scan
09/05
09/05/23 39 BADA, 82/M DIFFICULTY PULMONARY MASS, RIGHT T/C MALIGNANT DR. GALICIA (PC) A: PNSS 1L AT 60CC/HR
JUANITO OF HYPERTENSION STAGE 2
BREATHING D LOW FAT LOW SALT DIET
M VS Q4 I AND Q SHIFT
1. LOSARTAN 50 MG 1 TAB OD
09/05
CBC
WBC 13.1
RBC 4.7
HGB 12.8
HCT 0.40
PLT 316
N 0.73
L 0.17
M 0.07
E 0.02
B 0.01
K 4.49
NA 139.9
CREA 104
CA 1.26
MG 0.72
RAT NEGATIVE
09/05
09/05/23 226 BULLANDAY, 48/F DYSURIA PARTIAL INTESTINAL OBSTRUCTION SECONDARY TO DR. OTERO A D5LR 1L AT 100C/HR
CELSTINA RECTAL CARCINOMA R/O URINARY BLADDER
INFILTRATES HYPERTENSION STAGE 2 D LOW RESIDUE SOFT DIET
M VS Q4 I AND Q SHIFT
1. SULTAMIICILLIN 1.5 G IV Q6
3. BOWEL PREP
09/06/23 34 MALABON, 64/M BACK PAIN LUMBAR SPRAIN R/O FRACTURE DR. J. RAMOS (PC) A: PNSS 1L AT 50CC/HR IM
PEDRO PULMONARY MASS, RIGHT
D: DAT
M: VS Q4; I&O QSHIFT
I:
U: (49 KGS)
M:
L:
09/05
WBC 12.4
RBC 5.0
HGB 14.4
HCT 0.45
PLT 268
N 0.75
L 0.12
E 0.06
M 0.05
B 0.01
CREA 81
U:
09/05
9/05.23 ICU CATIPAY, 39.M BODY ARF TYPE 2 SECONDARY TO OSAHS DR. D BERNARDO A IVF PNSS 1L FD 500CC NOW THEN REGULATEAT 180 CC/HR IM
RICHARD MALAISE HYPERTENSION STAGE 2 (PC)
AKI ON TOP OF POSSIBLE CKD SEC TO HPNNS DR. MAGALLANES D START ENSURE 1800 KCAL / DAY IN 6 DIVIDED FEEDINGS
GOUTY ARTHRITIS NOT IN FLARE (CM)
M VS Q HOURLY AND I AND O Q HOURLY
U
M
ER REFERRALS: 1
09/05/23 202-1 GABIJAN, 54/F RUQ PAIN T/C MIRIZZI SYNDROME VS CHOLEDOCHOLELITHIASIS DR. PURACAN (PC) A PLR 1L @ 115 CC/HR SURG/IM
LORNA
NOT IN CHOLANGITIS DR. LACUNA (CP) D LSLF, NPO BY MIDNIGHT
M VSQ4, I&O QS
L 9/5
WBC 7.0
RBC 4.7
HGB 12.9
HCT 0.41
PLT 273
N 0.47
L 0.45
M 0.05
NA 145.4
K 3.90
CA 1.18
MG 1.03
DBIL 3.2
IBIL 5.9
TBIL 9.0
PT 12.1
CONTROL 13.0
INR 1.03
%ACT 89.10
U 9/5
09/05/23 204-6 SANDAY, 41/F EPIGASTRIC ACUTE CALCULOUS CHOLECYSTITIS DR. REGONDOLA A VENOCLYSIS SURG/IM
NELFE PAIN (PC)
HYPOKALEMIA SD: PNSS 500 CC + KCL 40 MEQS TO RUN IN 50 CC/HR
D SIPS OF WATER
M VSQ4, I&O QS
U CPK (KG)
L 9/5
U 9/5
09/05/23 204-1 OCIONES, 60/M EPIGASTRIC CHRONIC CALCULOUS CHOLECYSTITIS DR. D. A IVR PLR AT 100 CC/HR SURG/IM
MILAGROS PAIN BUENAVENTURA
(PC) D LOW FAT DIET/DAT
DR. MOSQUEDA I
(CM)
U 0.7 CPK (60 KG)
DR. M GONZAGA
(ANES) M
3. BUSCOPAN 10 MG IV Q8 PRN
L: 9/5
SGPT 11
U: 9/5
SCHEDULE TO FOLLOW
HOLDING AREA: 0
GEN MED I: 5
DATE RM PATIENT’S NAME AGE/ CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON FOR REMARKS SERVICES
ADMITTED SEX COMPLAINT REFERRAL
09/03/23 1 TABBOGA, 64/M PAIN LUNG CANCER STAGE IV WITH BONE AND LEFT CERVICAL DR. QUIAMBAO (PC) A D5NSS AT 25 CC/HR
DANIEL NODE METASTASIS
PNSS 1L @ 25 CC/HR
CHRONIC KIDNEY DISEASE SECONDARY TO URATE
NEPHROPATHY D LOW PROTEIN RENAL SOFT DIET
I PIPTAZ D1
U CPK
09/05
NO NEW LABS
09/05
08/24/2023 2 LAVINA, 69/F DYSPNEA 09/ 05 DR. YAP - ARANIEGO A: D5W 0.3 NACL 1L @ 10 CC/HR
PURIFICACION
DR. FLORESCA (CO- D: W/NGT 1800KCAL GLUCERNA IN6 DIVIDED FEEDINGS
MGT) (300CC); JELLY DIET TRIAL; BANANA BASED TRIAL FOR
ACUTE CVA INFARCT R MCA LUGAW; FEED WITH SAP
BA NOT AE M:
7. SPIRONOLACTONE (ALDACTONE) 25 MG 1
TAB OD
PRN MEDICATIONS
1.
09/05
NO NEW LABS
U:
09/05
MGH TODAY
09/05/23 3 CARTAJENA, 74/M DYSPNEA Pleural Effusion Left prob parapneumonic DR. B. RAMOS (PC) A PNSS @ KVO
SEGUNDINO
CAP - MR D low salt Low fat renal
U
M
2. Amlodipine 10 mg 1 tab OD
3. Losartan 50 mg 1 tab OD
5. Aspirin 80 mg 1 tab OD
6. Clopidogrel 75 mg 1 tab OD
7. Atorvastatin 40 mg 1 tab OD
09/05
CBC
ECG
Creatinine BUN
SGPT, Phosphorous
Pro BNP
UTZ of Chest
Blood cs x 2 sites
Sputum GSCS
09/05
08/11/23 5 LABADO, 72/M HEMATOCHE SEPTIC SHOCK SECONDARY TO HAP, MULTIPLE LUNG AND DR. ORCASITAS (PC) A: D5NSS 1L @ KVO RATE IM/SURG
BENJAMIN ZIA CHEST MASS METASTASIS VS TUMOR RECURRENCE VS
DOUBLE PRIMARY DR. HAW (CM) D: NO FOOD RESTRICTIONS; MAY HAVE SOFT DIET
WITH SAP
DR. YBIERNAS (CM)
M: VSQ4, I&O QS, O2 2 LPM/NC PRN
DR. P
BUENAVENTURA I: MEROPENEM 1 GM IVTT Q8 D3
(TSP)
U: CPK(49 KG)
DR. J PILAPIL
(ENDOSCOPY) M:
PRN MEDICATIONS
L:
9/5
NO NEW LABS
U: 9/5
A> HAP
P-
Vs monitoring q 2
CBG monitoring q 8
08/30/23 6 LAURENTE, 49/M LEFT- SIDED PTB-CAVITY, CLINICALLY DIAGNOSED; ACUTE CVA DR. M. ONG (PC) A PNSS 1L 100CC/HR
JERRY WEAKNESS INFARCT, RIGHT MCA
D DIABETIC
DM NEPHROPATHY
M VS Q4, I&O QSHIFT
TYPE 2 DM-IR
I MYRIN P FORTE D6
U: CPK (49KG)
1. ATORVASTATIN 80 MG 1 TAB OD @ HS
PRN MEDICATIONS
09/05
NO NEW LABS
09/05
MGH STILL IN
8/26/23 RM MAGLACION, 38/F CHILLS UROSEPSIS SECONDARY TO OBSTRUCTIVE UROPATHY DR. BAD-ANG A: PLR 1L AT 40C/HE IM
7 JEAN ISABEL S/P CYSTOSCOPY, DJ STENTING INSERTION LEFT
AKI SECONDARY TO OBSTRUCTIVE UROPATHY D: DAT
BA NOT IN AE
M: VS Q4; I&0 QSHIFT
I: ERTAPENEM D7
U: CPK (66.5KG)
M:
PRN MEDICATIONS
L:
09/05
NO NEW LABS
U:
09/05
DATE RM PATIENT’S NAME AGE/ CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON FOR REMARKS SERVICES
ADMITTED SEX COMPLAINT REFERRAL
9/04/23 9 ADRALES, 71/M DYSPNEA CAP-MR DR. MAGNO A PNSS 1L AT 90 CC/HR
GILBERT
CKD SECONDARY TO DKD D LOW SALT LOW FAT DIABETIC DIET
1. AMLODIPINE 10MG/TAB OD
2. ASPIRIN 80MG/TAB OD
8. FEBUXOSTAT 40MG/TAB OD
9. SIMVASTATIN 40MG/TAB OD HS
09/04
Mg 0.75
Hba1c 6.5
Bun 10.9
Ca 1.21
Crea 137
Sgpt 71
Na 143.1
K 3.95
09/05 3:30pm
ADMIT
08/27/23 10 DELA CRUZ, 66/F LEFT SIDED 8/28 DR ANUTA A IVF PNSS 1L AT 100CC/HR
EUFEMIA WEAKNESS
RIGHT FRONTAL LOBE MASS D LSLF, DD
HYPOTHYROIDISM I CEFIXIME D5
U CPK (60KGS)
08/31 M
2. METHIMAZOLE 5 MG 1 TAB OD
09/04
GLIOMA AT FRONTAL L
T II DM
HYPERTHYROIDISM 09/04
NO NEW LABS
09/05
MGH
09/04
08/31/23 11 STRONG, JEFFERY 65/M NON DR. RASHID (PC) CM A: PNSS 1L AT 100 CC/HR IM/SURG
ALAN HEALING NON-HEALING ULCER, RIGHT LEG WITH CELLULITIS
WOUND DR. D D: DAT
BUENAVENTURA
T/C PERIPHERAL ARTERIAL DISEASE ON TOP OF CHRONIC (CM) M: VS Q4; I&O QSHIFT
VENOUS INSUFFICIENCY
I: CIPROFLOXACIN D5
ACUTE KIDNEY INJURY SECONDARY TO INFECTION
CLINDAMYCIN D5
U: (141KG)
09/04 M:
4. OMEPRAZOLE 40 MG 1 TAB OD
5. TELMISARTAN 40 MG 1 TAB
PRE OP MEDS
PRN MEDICATIONS
L:
09/04
NO NEW LABS
0/05
NO NEW LABS
U:
09/04
CONTINUE MANAGEMENT
09/05
I:
M:
4. CEFTRIAXONE 2G IVTT OD
5. CLINDAMYCIN 300MG Q6
7. LACTULOSE 30CC OD @ HS
PRN MEDICATIONS
1. RI SLIDING SCALE
140-220 4 U SQ
221-260 6 U SQ
261-300 8 U SQ
>300 10 U SQ
3. EPIDURAL ANALGESIA:
L:
09/05
NO NEW LABS
U:
09/05
CONTINUE MONITORING
D/C CEFTRIAXONE
9/3/23 44 BACLAAN, LEAH 52/F SEIZURE GENERALIZED TONIC-CLONIC SEIZURE PROBABLY A D5W 1L @ 80 CC/HR IM
SECONDARY TO HYPONATREMIA SECONDARY TO GI LOSS
AND POOR ORAL INTAKE; HPN STAGE II IVF KVO
M VSQHOURLY, I/OQHOURLY
2. PANTOPRAZOLE
+DOMPERIDONE(PANTOPLUS) OD
LEVECITARETAM TO 500MG ½ TAB BID
PRN MEDICATION
09/05 1:15 PM
NA 141
9/4 NA 124
09/05 1:15 PM
REPEAT NA AT 8AM
DEC O2 TO PRN
MAY REMOVE FC
FF UP REPEAT S. NA
09/04
9/3/23 15 JARABE, JUANITO 70/F HEMOPTYSIS T/C PTB RADICULOPATHY, RIGHT LEG CAP-LR A PNSS 1L @ 70CC/HR IM
SR
D LOW SALT, LOW FAT, LOW PURINE DIET
I : CEPODOXIME D2
U CPK (65KG)
1. CLOPIDOGREL 75MG/TAB OD
2. AMLODIPINE 10 MG/TAB OD
3. ATORVASTATIN 10MG/TAB OD HS
09/04
NO NEW LABS
09/05
09/04
09/05
C/D IVF
09/05/23 39 BADA, JUANITO 82/M DIFFICULTY PULMONARY MASS, RIGHT T/C MALIGNANT DR. GALICIA (PC) A: PNSS 1L AT 60CC/HR
OF HYPERTENSION STAGE 2
BREATHING D LOW FAT LOW SALT DIET
M VS Q4 I AND Q SHIFT
2. LOSARTAN 50 MG 1 TAB OD
U
09/02/23 40 AVILA, GINA 58/F VOMITING T/C CATHETER RELATED BLOOD STREAM INFECTION DR. QUIREQUINCIA A: PNSS 1L @ KVO
(PC)
UREMIC GASTROPATHY D RENAL DIET
3. CLOPIDOGREL 75 MG OD
5. LINAGLIPTIN 5 MG OD
7. PIPTAZ 2.25 G IV Q6
PRN MEDICATIONS
09/05
NO NEW LABS
09/04
NO NEW LABS
09/05
REPEAT HD TOMORROW
REUSE DIALYZER 2X
09/04
08/22/23 43 ALMONIA, 62/F BODY PULMONARY CONGESTION SECONDARY TO AKI SEC TO CIN DR. LACUNA A: PNSS 1L TO 60CC/HR
THELMA WEAKNESS ON TOP OF SEPSIS (IMPROVING)
D SD
CAP-MR RESOLVING
M VS Q4 IO QS
SOLID MASS WITH INFILTRATES
I CEFEXIME D5
MEI: DECREASE NA, K - RESOLVING
U: CPK (58KG)
T2 DM IR
M 8/25
1. ATORVASTATIN 20MG/TAB OD HS
4. GLARGINE 14 UNITS SQ OD
5. AMLODIPINE 10 MG 1 TAB OD
PRN MEDICATIONS
1. RI SLIDING SCALE
2 UN 180-220
4 U 221-240
6 U 241-260
8U 261-300
10 U >300
L:
09/05 3:10 pm
No new labs
09/04
CXR
IMPRESSION
ATHEROSCLEROTIC AORTA
09/05 3:10pm
09/04
DC DEXAMETHASONE
08/28/23 14 DAITOL, 54/M LEFT SIDED 09/04 DR. MAGNO (PC) A : PNSS 60 CC/HR IM
ARTERMIO WEAKNESS
ACUTE CVA BLEED, RIGHT EXTERNAL CAPSULE ON TOP OF DR. ANUTA (CM) D ENSURE MILK 1600KCAL IN 6 DIVIDED FEEDINGS
MULTIPLE CHRONIC INFARCTS
M VSQ4, I&O QS
CAP-MR
I CEFIXIME 200 MG 1 TAB BID D2
HCVD
U: 1.7CPK `(55 KG)
CKD SEC TO HPNO
M
1. TELMISARTAN 80 MG TAB OD
2. AMLODIPINE 10 MG TAB OD
7. BISOPROLOL 5 MG 1 TAB OD
09/04
NO NEW LABS
09/05
09/04
DC MANNITOL
09/05
DO BLADDER TRAINING
08/04/23 46 MORING, FELIX 57/M RIGHT SIDED ACUTE CVA INFARCT VS BLEED DR.M. ALQUIZA A PNSS1L REGULATE AT 80 CC/HR
WEAKNESS
TYPE 2 DIABETES MELLITUS D DAT
U CPK
4.ATORVASTATIN 80MG/TAB OD HS
5. CEREBROLYSIN 10 MG IV Q12
09/05 1:40 PM
HBA1C 10.6
CHOL 6.1
HDL 1.40
LDL 3.98
TGL 1.67
09/05 1:40 PM
CONTINUE MEDS
09/02/23 47 ARISGADO, 75/F BODY MALAISE HYPERGLYCEMIC CRISES (HHS) DR. HO A PNSS 1L @ 100 CC/HR
CERINA
T/C UROSEPSIS SEC TO COMPLICATED UTI D NPO
I: CEFTRIAXONE D2
U CPK (65KG)
1. CEFTRIAXONE 2 GMS IV OD
3. FEBUXOSTAT 40 MG 1 TAB OD
5. GLARGINE 44 U SQ OD
STAT MEDICATIONS
PRN MEDICATIONS
2. RI 6 U 180 - 220
RI 8 U 221 - 260
RI 10 U > 260
09/05 12:30 PM
09/04
SUA 374
09/05 12:30 PM
FACILITATE USD OF WA
09/04
FEBUXOSTAT 40MG/TAB OD
INCREASE GLARGINE RO 32 U
FOR USD OF WA
DATE RM PATIENT’S NAME AGE/ CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON FOR REMARKS SERVICES
ADMITTED SEX COMPLAINT REFERRAL
U 1.3 CC/KG/HR(61KGS)
2. MONTELUKAST 10 MG 1 TAB OD HS
9/5
CBC
WBC 20.5
RBC 4.3
HGB 14.0
HCT 0.40
PLT CT 253
N 0.94
L 0.05
M 0.01
E 0.00
B 0.00
NA 144.3
K 2.21
MG 0.97
CA 1.25
CREA 99
UA:
LIGHT YELLOW
CLEAR
6.5
1.010
NEGATIVE
9/5
ADMIT
09/05/23 RM LLOREN, JOEL 54/M RUQ PAIN CHOLEDOCHOLITHIASIS DR. VELASCO (PC) A D5NSS 1L AT 100CC/HR IM
U CPK
L
09/05
WBC 6.9
RBC 4.0
HGB 12.4
HCT 0.38
PLT CT 257
N 0.79
L 0.15
M 0.04
CXRAY
PROTIME
09/05
09/01/2023 20 FERRARIS, 90/F COUGH COMMUNITY ACQUIRED PNEUMONIA - MODERATE RISK DR. LACUNA (PC) A PNSS @ 10CC/HR
FLORDELIZA WITH ASPIRATION COMPONENT
D LSLF
HYPERTENSIVE CARDIOVASCULAR DISEASE
M VSQ4, I&O QSHIFT
I PIPTAZ D0+2
2. MOXIFLOXACIN 400MG/TAB OD
09/05
WBC 6.0
PLT CT 189
RBC 5.5
HGB 16.3
S 0.62
HCT 0.49
L 0.21
M 0.09
E 0.07
B 0.01
09/05
9/4/22 LIMPANGOG, 51/M DYSPNEA PULMONARY CONGESTION SECONDARY TO CHF DR. MAGALLANES A PNSS 1L AT KVO IM
ORLY
FC II D DAT
M VSQ4
9. ATROVENT NEB Q6
09/05
TROP 150.8
09/05
FF UP CARDIO REFERRAL
CBR WITHOUT BP
09/05/23 22 DIONGSON, 86/M DECREASED Acute CVA Infarct prob posterior Cerebral artery NIHSS - 8 Dr. Licayan (PC) Dr. A PNSS 1L @ 100 cc/hr
AMIE SENSORIUM HCVD Abou zaki (CM)
D Soft diet with strict aspiration precaution
U 0.6 CC/KG/HR(70KGS)
1. Atorvastatin 80 mg 1 tab OD HS
2. Citicoline 1 gm IV q 12
09/05
IMPRESSION:
CXR
IMPRESSION:
PULMONARY CONGESTION
ATHEROSCLEROTIC AORTA
THORACIC SPONDYLOSIS
CBC
WBC 12.0
RBC 5.5
HGB 16.5
HCT0.49
PLT 230
N 0.84
L 0.09
M 0.04
E 0.02
B 0.01
MG 0.65
CA 1.12
CREA 101
K 3.08
NA 142.7
FT4 0.98
TSH
SUA 535
HBA1C 5.5
09/05
9/3/23 23 PADON, VICTOR 85/M LOSS OF PTB - CLINICALLY DIAGNOSED DR. QUIAMBAO A PNSS 1L AT KVO
APPETITE
T/C PULMONARY MASS D DAT
6. OMEPENTINE 40 MG IV OD
8. LEVOPRONT 10 ML TID
9/05
PT
TIME
INR 1.13
% ACT 79.00
9/05
09/02/23 24 ALENTAJE, ANNE 32/F FEVER AND BACTEREMIA SOURCE TO BE DETERMINED PROBABLY DR. S. GUILLERMO A IVF PNSS 1L AT 80CC/HR
CHILLS SECONDARY TO UTI
D DAT
PRN MEDICATIONS
09/05
09/05
U 0.7 CC/KG/HR(75KGS)
CEFTRIAXONE 2GM IV OD
L:
09/05
UTZ OF WA
URINALYSIS
WBC 1
RBC 15
EPITH CELLS 3
CAST 0
BACTERIA 1
PE
CHARACTER CLEAR
REACTION: 6.0
CE
SUGAR: NEG
PROTEIN +
U
09/05
ANTIBIOTICS
9/4/23 27 CORPUZ, 51/F LEFT LOWER HYPOVOLEMIC SHOCK PROB SECONDARY TO ACUTE DR. P. A: PNSS 1L AT 100CC/HR IM
JOCELYN QUADRANT BLOOD LOSS SEC TO BLEEDING. BUENAVENTURA (PC)
PAIN D: DAT, INCLUDE 2 EGG WHITES PER MEAL
RECTOSIGMOID MASS ON TOP OF SEPTIC SHOCK SEC TO
UROSEPSIS RECTOSIGMOID ADENOCARCINOMA M: VS Q4HRS; I/O QSHIFT
I:
U: 50KG
M:
PRN MEDICATIONS
L:
09/05
NO NEW LABS
U:
09/05
TYPE II DIABETES MELLITUS NON-INSULIN REQUIRING D PEG TUBE FEEDING: GLUCERNA 235 CC THEN
FLUSHE WITH 60 CC WATER, Q 4
HYPERTENSION STAGE II
M VS Q 4, I&O Q SHIFT
MAJOR DEPRESSIVE DISORDER
I
U:
1. KENZOLIN 4.5G IV Q6
STAT MEDICATIONS
PRN MEDICATIONS
1. RI SLIDING SCALE
6U FOR 221-260
09/05
CREATININE 65
ECG
NORMAL ECG
09/05
09/05/23 30 Revilla, Narciso 74/M Edema Pulmonary congestion prob secondary to Heart failure DR. OMBAO (HC) A PNSS @ KVO
Hypertensive Cardiovascular Disease, Heart Failure FC III MVS q4, I/O q shift
4. RI Sliding scale
CBG RI SQ
180-220 4 units
221-260 6 units
261-300 8 units
>300 10 units
09/05
WBC 9.7
Hgb 8.8
Hct 0.26
Plt 244
N 0.71
L 0.20
M 0.08
Albumin 18
SUA 491
Na+ 137.0
K+ 3.92
Ca++ 1.17
Mg+ 0.57
09/05
08/27/23 31 CAÑEDA, 22/M STIFFENING 09/05 DR. ANUTA (PC) A: C/D IVF SHIFT TO HEPLOCK IM
MAROEL
RPGN D: DAT
U: (60 KG)
M:
5. FEBUXOSTAT 40MG/TAB OD
6. NAHCO3 650MG/TAB OD
PRN MEDICATIONS
L:
09/05
NO NEW LABS
U:
09/05
FF UP ANTI-DSDNA AS OPD
08/12/23 32 TAJORA, 89/F COUGH 09/05 DR. LACUNA (PC) A: PNSS 1L @ 10 CC/HR IM
JACINTA
PLEURAL EFFUSION RIGHT DR. J. RAMOS (CM) D: SOFT DIET WITH STRICT ASPIRATION PRECAUTION,
LIBERAL SALT DIET
PROBABLY SECONDARY TO PTB VS MALIGNANCY R/O ACS DR. FAJARDO (CM)
M: VSQ4, I&O QS
DR. QUIBO (EVAL)
I:
M:
4. ZYKAST 1 TAB OD @ HS
7. OMEPRAZOLE 40 MG 1 CAP OD
PRN MEDICATIONS
L:
09/05
ABG
PH 7.42
PCO2 58.5
PO2 80.8
HCO3 39.0
02 SAT 95.7%
PO2 1.0
CREA 399
TROP I 168.4
U:
09/05
KEEP THERMOREGULATED
I:
M:
L:
09/05
WBC 12.4
RBC 5.0
HGB 14.4
HCT 0.45
PLT 268
N 0.75
L 0.12
E 0.06
M 0.05
B 0.01
CREA 81
U:
09/05
PICU: 0
DATE RM PATIENT’S AGE/ CHIEF COMPLAINT ADMITTING DIAGNOSIS PHYSICIAN REASON REMARKS SERVICES
ADMITTED NAME SEX FOR
REFERRAL
DATE RM PATIENT’S AGE/ CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON FOR REMARKS SERVICES
ADMITTED NAME SEX COMPLAINT REFERRAL
08/30/23 217-A TAYO, JASNA 25/F FATIGUE END STAGE RENAL DISEASE SECONDARY TO DR. MANALAYSAY A NO IVF IM
GLOMERULONEPHRITIS SECONDARY TO HYPERTENSION (PC)
D RENAL DIET
DR. DEL FIERRO
M VSQ4, I&O QS, WITH IJ CATH RIGHT NECK
FINAL DIAGNOSIS (IJ CATH)
I
END STAGE RENAL DISEASE SECONDARY TO CHRONIC
GLOMERULONEPHRITIS; STATUS POST INTRA JUGULAR U 0.9 CPK (73 KG)
CATHETER INSERTION RIGHT; STATUS POST INITIATION
HEMODIALYSISGLOMERULONEPHRITIS SECONDARY TO M
HYPERTENSION
5. CA+VIT D TAB OD
L: 9/5
U: 9/5
MGHSI
09/05/23 217-C HINGGOS, 64/M NON HEALING NON HEALING WOUND, LEFT ANTERIOR SHIN DR. RJ TAN (PC) A PNSS 1L @ 100 CC/HR IM
ANECITA WOUND, LEFT
ANTER TYPE II DIABETES MELLITUS D DD, ALLERGIC TO SEAFOOD AND CHICKEN
M VSQ4, I&O QS
I PIP TAZO D0
L 9/5
U 9/5
09/04/23 218-C BAYRON, 35/F LABOR PAIN T2DM - INSULIN REQUIRING DR. ROY (PC) A NO IVF OB/IM
MAYLEN
G3P1 (1011) PU 38 2/7 WEEKS AOG DR. EVORA (CM) D LSLF DIABETIC DIET
I SULTAMICILLIN D0+1
L 9/5
WBC 22.1, RBC 4.2, HGB 12.1, HCT 0.37, PC 203, N 0.74,
L 0.22, M 0.03, B 0.01
U 9/5
MGH OB WISE
REPEAT CBC
08/27/23 221 MONDAY, 81/M DYSPNEA ASTHMA-COPD OVERLAP IN ACUTE EXACERBATION DR. J. RAMOS (PC) A PNSS 1L @ KVO IM
AGUSTO
CAP-MR DR. ORCASITAS D LSLF
DR. P I
BUENAVENTURA
9/5 (CM) U 2.1 CPK (67 KG)
COPD IN AE M
L 9/5
WBC 17.7, RBC 4.2, HGB 12.2, HCT 0.38, PLT 378, N 0.82, L
0.09, M 0.07, E 0.02, B 0.00
FF UP 2D ECHO RESULTS
09/02/23 223 AGUILAR, 81/F RIGHT LOWER ACUTE APPENDICITIS DR. AGUILAR (PC) A PNSS 1L @ 100 CC/HR IM
VEVENCIOLA QUADRANT
PAIN HYPERTENSION STAGE 2 DR. VALDEZ (CM) SD: D5W 250 CC + MGSO4 2 GM X 24 HOURS
AKI SEC TO INFECTION DR. BANICO (CP) D5W 500CC +TRAMADOL 200MG 20CC/HR
4. OMEPRAZOLE 40MG IV OD
L 9/5
WBC 18.6, RBC 3.4, HGB 9.8, HCT 0.31, PC 352, N 0.81,L
0.09, M 0.08, E 0.02
CREA 100
U 9/5
M:
1. PANTOPRAZOLE 40 MG IV OD
5. ZYKAST 1 TAB OD
L: 9/6
WBC 11.6, RBC 4.4, HGB 12.2, HCT 0.36, PLT 60, N 0.37,
L 0.54, M 0.07, E 0.01, B 0.01
9/5
WBC 8.4, RBC 4.3 HGB 11.9, HCT 0.36, PC 57, N 0.34, L
0.57, M 0.09
U: 9/5
CBC Q8
09/01/23 224 PAMPLONA, 16/F FEVER DENGUE WITH WARNING SIGNS DR. QUIAMBAO A: PNSS 1L @ 100 CC/HR IM
PRECIOUS (PC)
D: DAT WITHOUT DARK COLORED FOODS
M:
1. PARACETAMOL 500 MG 1 TAB Q4 PRN FOR
FEVER
2. PANTOVEX 40 MG IV OD
3. ZYKAST 10 MG TAB OD
L: 9/6
WBC 3.6, RBC 4.6, HGB 12.7, HCT 0.38, PLT 147, N 0.31,
L 0.59, M 0.09, E 0.01, B 0.00
U: 9/5
SURGICAL WING: 12
DATE RM PATIENT’S AGE/ CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON REMARKS SERVICES
ADMITTED NAME COMPLAINT FOR
SEX REFERRAL
08/17/23 202-6 CAPOL, DAISY 46/F LEFT LOWER RECTOSIGMOID MASS DR. VALDEZ (PC) A: NO IVF SURG/IM
QUADRANT
AND SMALL UTERINE MYOMA DR. MAGNO (CP) D: DAT
HYPOGASTRIC
PAIN S/P CS DR. ONG- M: VSQ4, I&O QS
ABRANTES (TOS)
I:
DR. HAW (CM)
FINAL DIAGNOSIS U: 1.9 CPK (54 KG)
DR. PILAPIL (TSP)
PARTIAL INTESTINAL OBSTRUCTION SECONDARY TO M:
RECTOSIGMOID MASS TO CONSIDER MALIGNANCY DR. FUENTES (OFF)
1. DOLCET 1 TAB QID
DR. LINDO (ANES)
2. CAPTOPRIL 25MG 1 TAB SL IF BP >140/90
L: 9/5
U: 9/5
MGHSI
08/19/23 203-1 BEBELONI, PIL 37/M DISCHARGE ON COLOCUTANEOUS FISTULA DR. PURACAN (PC) A: NO IVF SURG/IM
ANTHONY RLQ
S/P APPENDECTOMY DR. BANZON (ANES) D: FULL DIET
I:
POTT’S DISEASE
U: 9/5
MGHSI
09/02/23 203-2 ALINSUB, 68/F INFECTED FOOT, INFECTED WOUND CALCANEAL AREA - RIGHT TYPE 2 DR. LACORDA (PC) A PNSS 1L @ 80 CC/HR SURG/IM
TERESITA RIGHT DIABETES MELLITUS – UNCONTROLLED HYPERTENSION
STAGE II CKD SEC TO DKD AND HKD STAGE 3B ANEMIA DR. MABUNGA D DD
SECONDARY TO CHRONIC DISEASE AND INFLAMMATION (ANES)
M VSQ4, I&O QS, CBG TID PRE MEALS
DR. PANUDA
I PIP TAZO D3, CLINDAMYCIN D3
9/5 (CP & CM)
U 1.0 CPK (50 KG)
ASCENDING FASCIITIS DR. DELES
M
T2DM POORLY CONTROLLED (CP & CM)
1. KETOANALOGUE 2 TABS TID
S/P BKA
2. PIPTAZO 4.5 GMS IV Q6H
HCVD, HF PEF
3. CLINDAMYCIN 600 MG IV Q8H
5. PREGABALIN 75 MG 1 CAP OD AT HS
L 9/5
U 9/5
REPEAT K
09/05/23 204-1 OCIONES, 60/M EPIGASTRIC CHRONIC CALCULOUS CHOLECYSTITIS DR. D. A IVR PLR AT 100 CC/HR SURG/IM
MILAGROS PAIN BUENAVENTURA
(PC) D LOW FAT DIET/DAT
DR. MOSQUEDA I
(CM)
U 0.7 CPK (60 KG)
DR. M GONZAGA
(ANES) M
7. BUSCOPAN 10 MG IV Q8 PRN
L: 9/5
SGPT 11
U: 9/5
SCHEDULE TO FOLLOW
09/04/23 204-3 CAPEDING, 72/F INFRAUMBILICA TO CONSIDER TUOOVARIAN ABSCESS RECURRENCE WITH DR. ENOJO (PC) A PLR 1L @ 90 CC/HR SURG/IM
DELILAH L MASS VESICOCUTANEOUS FISTULA FORMATION
DR. OMBAO (CM) D DD
STATUS POST VAGINAL HYSTERECTOMY (2017)
DR. LLANES (CM) M VSQ4, I&O QS, CBG TID
STATUS POST EXPLORATORY LAPAROTOMY FOR OVARIAN
ABSCESS (2021) I CEFTRIAXONE D1
9/5 M
3. AMLODIPINE 5 MG 1 TAB OD
5. BILASTINE 20 MG 1 TAB OD
9. CEFTRIAXONE 2 GM IV OD
L 9/5
HBA1C 7.2
U 9/5
FOR CT SCAN
08/27/23 205 ASUNCION, 74/M HEADACHE ACUTE OTOMASTOIDITIS WITH EXTENSION INTO THE DR. LEGITA (PC) A PNSS 1L @ 90 CC/HR SURG/IM
ROMUALDO SURROUNDING SOFT TISSUE OF THE PARAPHARYNGEAL,
MASTICATOR, CAROTID SPACE, RIGHT TO CONSIDER DR. TORNO (CM) D NGT FEEDING: DIABETIC DIET 1700 KCAL IN 6 DIVIDED
OSTEOMYELITIS CHRONIC ISCHEMIC INFARCT, PONS; TYPE 2 FEEDINGS
DM NON INSULIN REQUIRING DR. ANUTA (CM)
M VSQ4, I&O QS, CBG TID
DR. F. HO (CM)
I CEFEPIME D7, LINEZOLID D4
9/5 DR. GONZALES-SY
U 2.0 CPK (65 KG)
ACUTE OTOMASTOIDITIS, RIGHT (EVAL)
M
MASTOIDITIS LEFT,
1. CEFEPIME 1G Q8HRS
CHRONIC PONTINE ISCHEMIC INFARCT
2. CALMAG TAB BID
TYPE 2 DM - NIR
3. GLUSOL’N 18U SQ3HS
4. R1 18 U PRE FEEDING/MEALS
5. R1 10 U PRE FEEDING/MEALS
14. PANTOPRAZOLE 40 MG IV OD
L: 9/5
U: 9/5
09/04/23 207 TORMIS, 69/M HEMATURIA HEMORRHAGIC CYSTITIS DR. ENOJO (PC) A PLR 1L @ 100 CC/HR SURG/IM
ROLANDO
URINARY RETENTION SECONDARY TO ENLARGED PROSTATE DR. LINDO (ANES) D LSLF
I CEFTRIAXONE D0
HEMORRHAGIC CYSTITIS M
L 9/5
PSA 9.50
U 9/5
08/10/23 209 FAISAL, 25/M SOFT TISSUE SOFT TISSUE INJURY, LEFT LATERAL DR. YAMBAO-ARAO A: NO IVF IM/SURG
MUHADJER INJURY (PC)
MALLEOLUS, TO CONSIDER MULTIPLE FRACTURES SECONDARY D: DAT + EGG WHITES (STRICT ASPIRATION PRECAUTION)
TO MOTOR VEHICULAR ACCIDENT DR. MABUNGA ISLAM
(ANESTH)
M: VSQ4, I&O QS
DR. K. ROA (CM)
FINAL DIAGNOSIS I:
DR. K LIM (PLASTICS
OPEN ANKLE INJURY WITH AVULSED WOUND LATERAL ASPECT - CO MGT) U: 1.6 CPK(56 KG)
LEFT ANKLE CLOSED
DR. LACORDA (TSP) M:
FRACTURE MEDIAL MALLEOLUS LEFT ANKLE SECONDARY TO
ROAD TRAFFIC ACCIDENT 1. NORGESIC FORTE 1 TAB Q8
L: 9/5
U: 9/5
MGHSI
09/02/23 210 YONSON, 67/M DYSURIA BLADDER OUTLET OBSTRUCTION SECONDARY TO BLEEDING DR. ENOJO (PC) A PLR 1L @ 100 CC/HR SURG/IM
ELEUTERIO URINARY BLADDER TUMOR VS PROSTATOMEGALY
DR. KASILAG (CM) D LSLF
HYPERTENSION STAGE 2
M VSQ4, I&O QS
I CEFTRIAXONE D2
9/5
U 1.2 CPK (76 KG)
BLADDER OUTLET OBSTRUCTION SECONDARY TO BLEEDING
URINARY BLADDER TUMOR VS PROSTATOMEGALY M
2. CEFTRIAXONE 2 GM IV OD
3. AMLODIPINE 5 MG OD
4. LOSARTAN 50 MG OD
L 9/5
U 9/5
L 9/5
U 9/5
MGHSI
09/01/23 214 DOMINGO, 74/M HEMATURIA URINARY OUTLET OBSTRUCTION PROBABLY SECONDARY DR. DELA VICTORIA A: D5LR 1L @ 100 CC/HR SURG/IM
TIRSO MALIGNANT PATHOLOGY (PC)
PNSS 1L @ 100 OR KVO CC/HR
HYPERTENSIVE CARDIOVASCULAR DISEASE, CORONARY DR. MAGLANA (CM)
ARTERY DISSEASE D: DAT + 2 EGG WHITES
DR. GALLEMASO
S/P PACEMAKER INSERTION (CM) M: VSQ4, I&O Q4,
7. LIPITOR 40MG OD AT HS
L: 9/5
ATHEROMATOUS AORTA
PSA 6.61
U: 9/5
08/14/23 216 MICLAT, 59/M ABDOMINAL TO CONSIDER ACUTE APPENDICITIS VS. ACUTE DR. JAMIANA (PC) A NO IVF SURG/IM
ROBERTO PAIN CHOLECYSTITIS
DR. ENOJO (CM) D DAT
HYPOVOLEMIC SHOCK SECONDARY TO ACUTE BLOOD LOSS DR. PUNAY (CM) 2. KETOANALOGUE 1 TAB TID
SECONDARY TO BLEEDING RENAL MASS, LEFT
DR. VEGA-BUNO 3. CARVEDILOL 6.25MG 1 TAB BID
PLEURAL EFFUSION RIGHT PROBABLY PARAPNEUMONIC IN (EVAL)
4. COLCHICINE 1 TAB BID
ORIGIN ON TOP OF CONGESTION SECONDARY TO ACUTE
DECOMPENSATED HEART FAILURE
ACUTE KIDNEY INJURY SECONDARY TO RENAL 5. PARACETAMOL 650 MG 1 TAB TID
HYPOPERFUSION ON TOP OF INFECTION AND ANEMIA
SEVERE 6. ACUFLAM SPRAY APPLY TO AFFECTED
AREA TID
L 9/5
U 9/5
MGHSI
EXECUTIVE WING: 7
DATE RM PATIENT’S AGE / CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON REMARKS SERVICE
ADMITTE NAME SEX COMPLAINT FOR S
D REFERRA
L
09/05/23 226 BULLANDAY, 48/F DYSURIA PARTIAL INTESTINAL OBSTRUCTION SECONDARY TO RECTAL DR. OTERO (PC) A D5LR 1L @ 100 CC/HR IM
CELESTINA CARCINOMA R/O URINARY BLADDER INFILTRATES HYPERTENSION
STAGE 2 DR. MATUNOG (CM) D SOFT DIET
M VSQ4, I&O QS
1. SULTAMICILLIN 1.5 GM IV Q6
2. BISOPROLOL 5 MG 1 TAB OD
L 9/5
WBC 10, RBC 4.0, HGB 9.3, HCT 0.32, PLT 402, N 0.67, L 0.21,
M 0.08, E 0.04, B 0.00
ALB 39
U 9/5
FOR WA CT SCAN WITH CONTRAST TOMORROW 1 PM
08/22/23 227 PADILLA, 58/M RESTLESSNESS UREMIC ENCEPHALOPATHY SECONDARY TO ESRD SECONDARY TO DR. VILLANUEVA (PC) A PNSS 1L @ 10 CC/HR IM
ELORDE HYPERTENSIVE NEPHROSCLEROSIS
DR. YBAÑEZ (CM) D5NSS 1L @ 80 CC/HR
HYPERTENSION STAGE 2
DR. ALCASID (CM) D LSLF, SOFT DIET WITH SAP
GOUTY ARTHRITIS NOT IN FLARE
DR. MANSILLA (TSP) M VSQ4, I&O QS, CBG TID, O2 3 LPM/NC
DR. BANGOY I
9/5
(TUBE U 0.6 CPK (44 KG)
SHOCK CARDIOGENIC ON TOP OF SEPTIC ENCEPH SECONDARY TO CHOLECYSTOMY)
CRBSI M
DR. ABOUZAKI (CM)
MODERATE CHOLECYSTITIS 1. FEBUXOSTAT 40 MG 1 TAB OD
DR. M VILLANUEVA
ESRD SEC. TO HPNNS (SURG CONSULT) 2. PANTOPRAZOLE 40 MG 1 TAB OD
L 9/5
U 9/5
08/14/23 228 MONDAY, 48/F DECREASED SECONDARY HEADACHE PROBABLY SECONDARY TO SPACE DR. YBAÑEZ (PC) A NO IVF IM
PANCHITA SENSORIUM OCCUPYING LESION
DR. J. TORRES (CM) D SD, DD, LSLF, NO CHICKEN
T/C CENTRAL VENOUS SINUS THROMBOSIS
DR. ONGKINGCO M VSQ4, I&O QS
HPN STAGE 2 (EVAL)
I
DR. VALLES (TSP)
U 1.0 CPK (72 KG)
FINAL DIAGNOSIS DR. DY. K (EVAL)
M
INTRACRANIAL, EXTRA-AXIAL MASS LESION, PARASAGITTAL DR. LAGAPA (CM)
BIFRONTAL MENINGIOMA WITH POSSIBLE SAGITTAL SIMS 1. LOSARTAN 100 MG 1 TAB OD
COMPRESSION; TYPE 2 DIABETES MELLITUS WITH STEROID INDUCED DR. BAGIS (EVAL)
HYPERGLYCEMIA;HYPERTENSION STAGE II 2. HEMARATE FA 1 TAB OD
DR. MADAYAG (REHAB)
3. ATORVASTATIN 40MG 1 TAB ODHS
6. GLARGINE 24 U SC ODHS
8. AMLODIPINE 10 MG 1 TAB OD
L 9/5
U 9/5
MGHSI
08/30/23 229 ALIAN, DIANA 84/F DYSPNEA CARDIOGENIC SHOCK SECONDARY ACUTE DECOMPENSATED HEAR DR. ARSOLON (PC) A PNSS 1L @ 10 CC/HR IM
FAILURE
DR. MAGALLANES (CM) SD: FURO 100 MG + 100 PNSS @ 10 CC/HR
HYPERTENSIVE CARDIOVASCULAR DISEASE
DR. YARRA (IJ CATH) D ENSURE 1400 KCAL IN 6 DIVIDED FEEDINGS
CHRONIC KIDNEY DISEASE SECONDARY TO HYPERTENSIVE KIDNEY
DISEASE DR. YBAÑEZ (TOS) M VSQ1, NVSQ, I&O Q1, O2 MECHVENT, CBG Q6
8. PERAMPANEL 4 MG 1 TAB OD HS
9. ATORVASTATIN 40 MG 1 TAB OD HA
L 9/5
U 9/5
DNI/DNR
09/01/23 230 MAGNO, 86/F UNRESPONSIV T/C SEPTIC VS METABOLIC ENCEPHALOPATHY DR. ABOUZAKI (PC) A: PNSS @ 400 CC/HR IM
ALICIA E
HYPERTENSIVE CARDIOVASCULAR DISEASE, LVH, HEART FAILURE DR. ARSOLON (CM) D: GLUCERNA FEEDING 1800 KCAL IN 6 DIVIDED FEEDINGS
WITH PRESERVED EJECTION FRACTION
DR. CABAHUG (CM) M: VS Q1, I&O Q1
CHRONIC KIDNEY DISEASE SECONDARY TO HYPERTENSIVE KIDNEY
DISEASE / DIABETIC KIDNEY DISEASE DR. AYCO (CM) I: MEROPENEM D1
S/P CVA 1998 WITH RESIDUAL LEFT SIDED WEAKNESS DR. VEGA-BUNO (AMS) U: 0.6 CPK (65 KG)
L: 9/5
U: 9/5
DNR/DNI
HOLD EEG
DR. BARINAGA (ANES) D: ENSURE 1800 KCAL/ DAY IN 1:1 DILUTION Q3 IN 7 DIVIDED
FEEDINGS BANANA BASED (6AP-9AP-12AP-3P) 250 CC
FINAL DIAGNOSIS DR. ORCASITAS (CM)
M: VSQ4, I&O QS, O2 1 LPM/NC
RIGHT CAPSULOGANGLIONIC HYPERTENSIVE BLEED DR. PUNAY (TSP)
I:
S/P RIGHT FRONTOTEMPORAL CRANIOTOMY; EVACUATION OF BLEED DR. HERRERA (REHAB)
U: 1.8 CPK (98 KG)
M:
1. TELMISARTAN 80 MG 1 TAB OD
2. AMLODIPINE 10 MG 1 TAB OD
U: 9/5
CONTINUE REHAB
08/22/23 233 ASERIOS, 67/M DYSPNEA ACS ANTEROSEPTAL WALL STEMI KILLIPS III DR. COCHING (PC) A: NO IVF IM
ROMEO
CAP HR (HYPOXEMIA); RULE OUT METASTATIC PROCESS DR. B. CHIEW (TSP) D: LSLF (PLANT BASED) ALLERGIC TO SEAFOOD
ON TOP OF CKD SECONDARY TO DKD AND HPNSS WITH RENAL ANEMIA DR. TOM (CM) I:
HCVD, SR, IHD, HF REF (40%) DR. PUNAY (TSP) U: 0.9 CPK (65 KG)
T2DM NIR M:
2. ASPIRIN 80 MG 1 TAB OD
ACUTE KIDNEY INJURY SEC TO INFECTION ON TOP OF CHRONIC KIDNEY 6. EMPAGLIFLOZIN 25 MG ½ TAB OD
DISEASE HYPERTENSIVE NEPHROSCLEROSIS
7. GLICLAZIDE 60 MG 1 TAB OD
HYPERTENSIVE CARDIOVASCULAR DISEASE, ISCHEMIC HEART DISEASE
8. CONCOR 2.5 MG 1 TAB OD
TYPE 2 DM
9. ALLOPURINOL 300 MG 1 TAB OD
L: 9/5
U: 9/5
MGHSI
ICU: 2
DATE RM PATIENT’S NAME AGE/ CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON FOR REMARKS SERVICES
ADMITTED SEX COMPLAINT REFERRAL
09/04/23 ICU-3 CONCEPCION, 46/M DYSPNEA PULMONARY CONGESTION PROBABLY SECONDARY TO HEART DR. BONJE (PC) A LEFT: PNSS 1L @ 5 CC/HR IM
DEXTER FAILURE
DR. ELORDE RIGHT: PNSS 1L @ 10 CC/HR
COMMUNITY ACQUIRED PNEUMONIA – HIGH RISK (CM)
SD: PNSS 100 CC + 40 MEQS KCL @ 20/HR X 3 CYCLES
T/C CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ACUTE DR. FADERAN
EXACERBATION (CM) D LSLF (DM DIET)
AKI SECONDARY TO INFECTION ON TOP OF CKD SEC TO DKD/ DR. M VSQ1, NVSQ1, I&O Q1
HKD DILANGALEN
(TSP) I
ANEMIA (MULTIFACTORIAL) SEC TO INFLAMMATION / CKD
DR. LEE (AMS) U 2.9 CPK (75 KG)
MULTIPLE ELECTROLYTES IMBALANCE
DR. FRANCO M
HYPERTENSIVE CARDIOVASCULAR DISEASE (TSP)
1. SALBUTAMOL + IPRA NEB Q6 + 2 CC PNSS
TYPE 2 DIABETES MELLITUS – INSULIN REQUIRING
2. FENOFIBRATE (LIPWAY) 160 MG 1 TAB OD
S/P CVA 2021 WITH LEFT SIDED RESIDUAL WEAKNESS
3. ATORVASTATIN (LIPITOR) 80MG 1 TAB OD
S/P BKA LEFT
4. ALPHA LIPOIC ACID 600 MG 1 TAB OD
AKI SECONDARY TO INFECTION ON TOP OF CKD FROM DKD, 12. CALMAG 1 TAB TID
HKD
13. HYDROCORTISONE 100MG IV 98
21. FUROSEMIDE 40 MG IV 98
L 9/5
K 3.29, MG 1.05
U 9/5
FF UP 2D ECHO RESULTS
09/05/23 ICU-8 CATIPAY, 39/M BODY ACUTE RESPIRATORY FAILURE TYPE 2 SECONDARY TO DR. D A PNSS 1L @ 180 CC/HR IM
RICHARD MALAISE OBSTRUCTIVE SLEEP APNEA HYPOPNEA SYNDROME BERNARDO (PC)
HYPERTENSION STAGE 2 DR. D START ENSURE 1800 KCAL/DAY IN 6 DIVIDED FEEDINGS
MAGALLANES
ACUTE KIDNEY INJURY ON TOP OF POSSIBLE CHRONIC KIDNEY (CM) M VSQ1, NVSQ1, I&O Q1, O2 MECHVENT
DISEASE SECONDARY TO HYPERTENSIVE NEPHROSCLEROSIS
I PIP TAZO D0
GOUTY ARTHRITIS NOT IN FLARE
U CPK (62 KG)
L 9/5
ATHEROMATOUS AORTA
TROP I 0.13
WBC 17.5, RBC 6.4, HGB 17.6, HCT 0.60, PLT 219, N 0.74, L 0.16, M
0.07, E 0.02, B 0.01
U 9/5
DATE RM PATIENT’S NAME AGE/ CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON FOR REMARKS SERVICES
ADMITTED SEX COMPLAINT REFERRAL
08/24/23 235-1 PISIAO, 51/F COUGH HYPERTENSIVE URGENCY DR. ANUTA (PC) A PNSS 1L @ 80 CC/HR SURG/
IM
LILIA DR. M HERRERA D DAT + 1 BANANA/MEAL
(CM)
FINAL DIAGNOSIS M VSQ4, I&O QS, CBG BID, O2 PRN
DR. FLORESCA
ACUTE CEREBROVASCULAR ACCIDENT RIGHT MIDDLE CEREBRAL (TSP) I
ARTERY
U 1.1 CPK (54 KG)
HOSPITAL ACQUIRED PNEUMONIA
M
ASYMPTOMATIC HYPERURICEMIA
1. FEBUXOSTAT 40 MG TAB OD
2. ATORVASTATIN 80 MG TAB OD
3. CITICOLINE 1 GM IVTT
4. CLOPIDOGREL 75 MG TAB OD
5. PANTOPRAZOLE 40 MG TAB OD
9. AMLODIPINE 10 MG 1 TAB OD
L 9/5
U 9/5
MGH
08/18/23 235-4 PEPANIA, 73/F DIZZINESS HYPERTENSIVE URGENCY DR. MAGNO A: NO IVF IM
ESTERLITA (PC)
TYPE 2 DM NON INSULIN REQUIRING D: BANANA BASED W/ GLUCERNA 1800 KCAL IN 6 DIVIDED FEEDINGS
DR. LEGITA (CM) WITH SAP (300 CC)
TO CONSIDER COMPLICATED UTI
DR. HERRERA M: VSQ4, I&O QS
(REHAB)
I:
FINAL DIAGNOSIS
U: 0.4 CPK (54 KG)
ACUTE CEREBROVASCULAR INFARCT - RIGHT MIDDLE CEREBRAL
ARTERY M:
5. AMLODIPINE 10 MG 1 TABLET OD
6. ATORVASTATIN 40 MG 1 TAB OD @ HS
20 U PRE DINNER
PRN MEDICATIONS
L: 9/5
U: 9/5
MGHSI
DATE RM PATIENT’S NAME AGE/ CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON FOR REMARKS SERVICES
ADMITTED SEX COMPLAINT REFERRAL
OBGYNE WING: 0
DATE RM PATIENT’S AGE/ CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON REMARKS SERVICES
ADMITTED NAME SEX COMPLAIN FOR
T REFERRAL
DISCHARGED: 10
DATE RM PATIENT’S AGE/ SEX CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON FINAL DIAGNOSIS SERVICE
ADMITTED/ NAME COMPLAINT FOR S
DISCHARGED REFERRAL
08/28/23 201- MANLIGOY, 47/M NASAL NASAL POLYP LEFT DR. LLAMERA (PC) BILATERAL NASAL POLYPOSIS WITH PANSINUSITIS SURG/
1 CLOYD CONGESTION IM
HYPERTENSION STAGE II DR. VILLAROSA HYPERTENSION STAGE II
(ANES)
S/P ENDOSCOPIC SURGERY; POLYPECTOMY; ETHMOIDECTOMY, ANTROSTOMY
DR. GUILLERMO BILATERAL
(CP AND CM)
09/02/23 220 GONZALES, 61/M FOR COLON CANCER ST IV WITH LIVER AND PULMONARY DR. GALICIA (PC) COLON CANCER STAGE IV IM
CARLOS CHEMOTHER METASTASES
APY
HYPERTENSION STAGE 2
08/30/23 240 MONTAÑO, 36/F BREECH GRAVIDA 2 PARA 1 (1001) PREGNANCY UTERINE 37 1/7 DR. VELIGANIO GRAVIDA 2 PARA 2 (2002) PREGNANCY UTERINE DELIVERED TERM BREECH OB/IM
CARMELA PRESENTATION WEEKS AGE OF GESTATION BREECH IN LATENT PHASE OF (PC) LIVEBIRTH BABY GIRL APGAR 8,9 BIRTHWEIGHT 4610 GRAMS BALLARD SCORE
LABOR; GESTATIONAL DIABETES MELLITUS INSULIN 38 WEEKS LARGE FOR GESTATIONAL AGE VIA PRIMARY LOW SEGMENT
REQUIRING; GESTATIONAL HYPERTENSION; FETAL DR. VELIGANIO TRANSVERSE CESAREAN SECTION SECONDARY TO MALPRESENTATION AND
(ANES)
MACROSOMIA; FETAL MACROSOMIA UNDER SUBARACHNOID BLOCK ANESTHESIA; DIABETES
MELLITUS INSULIN REQUIRING; GESTATIONAL HYPERTENSION; FETAL
DR. LUY (CM)
ADVANCED MATERNAL AGE, POLYHYDRAMNIOS MACROSOMIA; POLYHYDRAMNIOS
09/04/23 220 TANCONTIAN 47/F FOR INVASIVE DUCTAL CARCINOMA STAGE III (T3N1M0), LEFT DR. GALICIA (PC) IM
, MIRIAM CHEMOTHER
APY S/P EXCISION OF BREAST MASS WITH FSB LEFT, MODIFIED
RADICAL MASTECTOMY, LEFT
FINAL DIAGNOSIS
09/02/23 201- MATUTE, 61/M HEMATOCHEZIA ANAL MASS, PROBABLY MALIGNANT DR. PURACAN ANAL MASS, PROBABLY MALIGNANT SURG/
6 ALFREDO (PC) IM
ESSENTIAL HYPERTENSION ESSENTIAL HYPERTENSION
DR. BANSON
(ANES)
08/31/23 208 CABACTULA 34/M SWELLING OF CELLULITIS, LEFT LEG DR. BORJE (PC) CELLULITIS, LEFT LEG SURG/
N, DENNIS LEFT FOOT IM
DR. FERRER (CM)
08/31/23 19 BRIONES, 34/F FEVER DENGUE W/ WARNING SIGN R/O RHD DR. MAGNO DENGUE WITH WARNING SIGNS IM
JOSEILEEN
09/01/23 34 TAJOS, 32/M PALLOR 09/05 DR. TOM (PC) UPPER GASTROINTESTINAL BLEEDING SECONDARY TO EROSIVE GASTRITIS, IM
JOSEPH SEVERE ANEMIA SECONDARY TO UPPER GASTROINTESTINAL BLEEDING
ANEMIA SECONDARY TO UGIB ON TOP OF RENAL ESRD CHRONIC KIDNEY DISEASE STAGE 5 SECONDARY TO CHRONIC
SEC TO CHRONIC GLOMERULONEPHRITIS SEC TO GLOMERULONEPHRITIS
HYPERTENSION T/C HYPOPROLIFERATIVE ANEMIA
08/27/23 38 OLEDAN, 70/F DISORIENTATI SEPTIC ENCEPHALOPATHY, SOURCE TO BE DETERMINED DR. RASHID (PC) SEPTIC ENCEPHALOPATHY SECONDARY TO ASPIRATION PNEUMONIA, IM
VIVIEN ON RIGHT;ACUTE KIDNEY INJURY SECONDARY TO INFECTION
HYPERTENSIVE CARDIOVASCULAR DISEASE
09/01
HCVD
T II DM NIR
08/30/23 226 COLLANTES, 44/M CHEST PAIN ACS NSTEMI PROB SECONDARY TO DRUG RELATED DR. OMBAO ACUTE CORONARY SYNDROME-NON ST ELEVATION IM
VENGIE CARDIOMYOPATHY
(PC) MYOCARDIAL INFARCTION KILLIP I
DATE RM PATIENT’S AGE/SEX CHIEF ADMITTING DIAGNOSIS PHYSICIAN TRANSFER TO REASON FOR FINAL DIAGNOSIS SERVICE
ADMITTED NAME COMPLAINT REFERRAL
TRANSFER TO ICU: 0
DATE RM PATIENT’S AGE/SEX CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON REMARKS SERVICES
ADMITTED NAME COMPLAINT FOR
REFERRAL
DATE RM PATIENT’S AGE/ CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON REMARKS SERVICES
ADMITTED NAME SEX COMPLAINT FOR
REFERRAL
WARD MORTALITY: 0
DATE RM PATIENT’S AGE/ CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON FOR FINAL DIAGNOSIS SERVICES
ADMITTED NAME SEX COMPLAINT REFERRAL
ER MORTALITY: 0
DATE RM PATIENT’S AGE/SEX CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON FINAL DIAGNOSIS SERVICES
ADMITTED NAME COMPLAINT FOR
REFERRAL
ICU MORTALITY: 0
DATE RM PATIENT’S AGE/SEX CHIEF ADMITTING DIAGNOSIS PHYSICIAN REASON FINAL DIAGNOSIS SERVICES
ADMITTED NAME COMPLAINT FOR
REFERRAL